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Abstract.  MG-63 human osteosarcoma cells were 
selected for attachment and growth in the presence of 
increasing concentrations of a  synthetic peptide con- 
mining the cell attachment-promoting  Arg-Gly-Asp se- 
quence derived from the cell-binding region of fibro- 
nectin.  Ceils capable of attachment and growth in 
5-mM concentrations of a peptide having the sequence 
Gly-Arg-Gly-Asp-Ser-Pro overproduce the cell surface 
receptor for fibronectin.  In contrast,  these cells show 
no differences in the numbers of vitronectin receptor 
they express as compared with the parental MG-63 
cells. In agreement with the resistance of the selected 
cells to detachment by the peptide, 25-fold more Arg- 
Gly-Asp-containing peptide is required to prevent the 
attachment of these cells to fibronectin-coated surfaces 
than is needed to inhibit the attachment of MG-63 
cells to the same substrate.  However, similar concen- 
trations of this peptide inhibit attachment of both cell 
lines to vitronectin-coated surfaces. The increase in 
fibronectin receptor is due to an increase in the levels 
of mRNA encoding the fibronectin receptor. Because 
of the nature of the selection process, we reasoned 
that this increase might be due to amplification of the 
fibronectin receptor gene, but no increase in gene copy 
number was detected by Southern blot analysis.  The 
peptide-resistant cells display a very different morphol- 
ogy from that of the MG-63 cells, one that has a 
greater resemblance to that of osteocytes. The resistant 
cells also grow much more slowly than the MG-63 
cells. The increased fibronectin receptor and altered 
morphology and growth properties were stable for at 
least 3 mo in the absence of peptide. The enhanced 
expression of the fibronectin receptor on the resistant 
ceils indicates that cells are capable of altering the 
amount of fibronectin receptor on their surface in re- 
sponse to environmental  factors and that this may in 
turn affect the phenotypic properties of the cell. 
HESION of cells to extracellular  matrix components 
appears to be fundamental  in cell behavior patterns 
such as cell division, cell differentiation,  and em- 
bryonic cell migration  and sorting.  Tumor invasion and me- 
tastasis may also occur due to altered mechanisms of adhe- 
sion of cells to the extracellular  matrix (Ruoslahti,  1984; 
Roos, 1984; Liotta,  1986). Fibronectin is a well character- 
ized component of the extracellular  matrix and promotes cell 
attachment  and  spreading  (Klebe,  1974; Peadstein  et al., 
1976; Rubin et al., 1979; Ruoslahti and Hayman, 1979; Grin- 
nell, 1980; Hynes and Yamada, 1982) as well as a variety of 
changes in cellular behavior (Ali and Hynes, 1978; Penny- 
packer et al., 1979; Loring et al., 1982; Yamada, 1983; Ruos- 
lahti  et al.,  1985). The cell-binding  domain of fibronectin 
contains the sequence L-arginyl-gtycyl-L-aspartic acid (RGD) 
which can  account for the ability of cells to  specifically 
recognize and bind to fibronectin (Pierschbacher  et al., 1983; 
Pierschbacher and Ruoslahti,  1984a, b). Synthetic peptides 
containing this sequence promote cell attachment when used 
to coat plastic surfaces and inhibit the attachment  of cells to 
fibronectin-coated  surfaces when presented in a soluble form 
(Pierschbacher and Ruoslahti,  1984a; Yamada and Kennedy, 
I984).  Thus,  various cultured cell lines  become detached 
from the substratum and their growth is arrested in the pres- 
ence of such active peptides (Hayman et al.,  1985). In vivo 
such peptides have also been found to inhibit gastrulation  in 
amphibian  embryos and neural crest cell migration  in avian 
embryos (Boucaut et al., 1984) and to reduce dissemination 
of malignant ceils to lungs in experimental  metastasis (Hum- 
phries et al.,  1986). 
A cell surface receptor interacting  with fibronectin  in an 
RGD-dependent manner has recently been isolated from hu- 
man osteosarcoma cells (Pytela et al.,  1985a). Other adhe- 
sion-promoting  molecules such as the collagens,  laminin, 
and vitronectin  are also present in the extracellular  matrices 
of cells and contribute significantly  to cell adhesion,  some 
apparently via similar mechanisms,  since some collagens 
03ernard  et al.,  1983) and vitronectin  (Suzuki et al.,  1985) 
also contain the RGD sequence, and interact with their own 
specific RGD-directed receptors (Pytela et al.,  1985b; Ded- 
har et al., 1987). Moreover, a chicken adhesion receptor in- 
teracts with fibronectin  and laminin  via an RGD-dependent 
mechanism (Hasegawa et al.,  1985; Horwitz et al.,  1985). 
One could predict, therefore,  that selection of cells with the 
ability to attach and grow in the presence of synthetic pep- 
tides containing the RGD sequence should result in cell lines 
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more of these receptors. Cell lines with such an altered phe- 
notype would be useful in the further analysis of receptor- 
ligand interactions and also in increasing our understanding 
of the physiological role(s) of these receptors. 
We report here that culturing MG-63 human osteosarcoma 
cells in increasingly high concentrations of a synthetic pep- 
tide, Gly-Arg-Gly-Asp-Ser-Pro (GRGDSP), results in cells 
capable of attaching and spreading in culture in the presence 
of high concentrations of this peptide. These ceils overpro- 
duce fibronectin receptors but not vitronectin receptors and 
are morphologically different from the parental MG-63 cells. 
Materials and Methods 
Materials 
Protein A Sepharose and FITC-conjugated  goat anti-rabbit IgG were pur- 
chased from Sigma Chemical Co.  (St.  Louis, MO).  usI-sodium iodide, 
~C-mefl~lated  molecalar weight standards, and 132pldCTP were purchased 
from New England Nuclear (Boston, MA). Chemicals used for SDS-PAGE 
were from Bio*Rad Laboratories (Richmond, CA).  Anti-HLA antiserum 
was the kind gift of Dr. David Cheresb, Scripps Research Institute, La Julia, 
CA. Anti-epidermal growth factor receptor antibody was a kind gift from 
Dr. E. Adamson of this institution.  Peptides were synthesized using a pep- 
tide synthesizer with the chemistry provided by the manufacturer (model 
430A;  Applied.Biosysterca,  Inc., Foster City, CA). 
Cells and Growth Conditions 
Human osteosarcoma (MG-63) cells (Billiau et al.,  1977) were obtained 
from American Type Culture Collection (Rockville,  MD). The cells were 
cultured in DME,  supplemented with 10% heat-inactivated  FBS (Tissue 
Culture Biologicals, Tulare, CA), glutamine (2 raM), penicillin (100 U/ml), 
and streptomycin (100 Itg/ml) (I.rvine Scientific, Santa Arm, CA). For rou- 
tine subculturing cell monolayers  were washed with PBS (150 mM NaC1, 
10 mM sodium phosphate, pH 7.3),  and detached with EDTA (1 raM). 
MG-63 cells were cultured in the presence of GRGDSP and GRGESP 
peptides as discussed in Results. The peptides were dissolved in DME and 
the pH was adjusted to 7.0 with sodium bicarbonate (7.5%).  The solutions 
were then filter-sterilized  before use. 
Cell Staining and Flow Cytometric Analysis 
Cell preparations were stained by indirect immunofluorescence  and ana- 
lyzed using a fluorescence-activated  cell sorter (Cytofluorograf  50H with 
2150 computer system,  Ortho Diagnostic Systems Inc., West~x~d, MA). 
The  primary  antibodies  used  were  affinity-purified  rabbit  polyclonal 
anti-MG-63 vitronectin receptor and anti-MG-63 fibronectin  receptor anti- 
bodies, rabbit anti-mouse epidermal growth factor receptor antiserum, and 
anti-HLA antibody.  The second antibody used was FITC-eonjugated  goat 
anti-rabbit IgG.  FITC  fluorescence  was  detected  as green fluorescence. 
Propidium iodide  was used to label nonviable cells and detected  as red 
fluorescence.  Cell size was estimated by forward  light scatter. 
lmmunoprecipitation 
MG-63 and peptide-resistant variant cells were detached from culture with 
EDTA (1 raM) and resuspended with PBS containing CaCI~ (1 raM) and 
MgCI2 (1 mM). The cells (,,02 ￿  106) were surface-labeled  with 12sI  as de- 
scribed previously  (Pytela et al.,  1985a; Lebien et al.,  1982) and lysed in 
PBS containing SDS  (0.1%),  Triton X-100 (0.5%), sodium deoxyeholate 
(0.5%), and PMSF (1 raM) for 15 min at 4~  The solubilized ceils were 
cleared of debris by centrifugation and cell extracts containing equivalent 
amounts of ~2~I  radioactivity  were immunoprecipitated  with the appropriate 
antibodies by coprecipitation with protein A Scpharose.  The antigen-anti- 
body complex was dissociated by boiling in sample buffer (200 mM Tris- 
HC1, pH 6.8 containing 3% SDS,  10% glycerol, and 0.001% bromphenol 
blue).  Samples  were  analyzed by electrophoresis under reducing (5% 
2-mercaptoethanol) or  nonreducing conditions in 7.5%  SDS-pulyacryl- 
amide gels (Laemmli, 1970) followed by autoradiography. 
RNA Dot Blot and Southern Blot Analysis 
Total  cellular  RNA  was  prepared by the guanidinium/cesium chloride 
method of UUrieh et al. (1977) as described by Maniatis et aL (1982). The 
RNA solution was adjusted to 20 mM sodium phosphate, pH 6.8, in 50% 
formamide (7% CV/V) formaldehyde and incubated at 65~  for 15 rain to 
denature  the RNA. Dilutions were then made in 11  x  SSC (1  ￿  SSC is 0.15 M 
NaCI, 1.5 mM sodium citrate) containing 37% formaldehyde and the RNA 
was applied to nitrocellulose filters that had been rinsed in 20x SSC. After 
baking at 80~  for 2 h  in a vacuum oven, the filters  were probed with 
[32P]cDNAs as described below for the Southern blot analysis. 
For restriction enyzme analysis, the high molecular weight DNAs were 
isolated from cells by the procedures of  Blin and Stafford (1976). The restric- 
tion endonucleases were purchased from Bethesda Research Laboratories, 
Bethesda, MD and were used according to the directions of the manufac- 
turer.  Digestion was  followed  to completion by mini-gel  analysis.  The 
digested DNAs were subjected to electrophoresis on 0.8% agarose gels in 
Tris/borate/EDTA  buffer (Maniatis et al.,  1982). After alkali denaturation 
and neutralization,  the DNA was transferred to nitrocellulose  paper (South- 
ern,  1975). After baking the filter at 80"C for 2 h in a vacuum oven, the 
filter was prehybridized  at 42"C in a solution containing 50% formamide, 
5x  Denhardt's reagent,  5x  SSPE  (Ix  SSPE  is  150 mM NaCI,  10 mM 
NaH2PO4,  1 mM EDTA),  0.1% SDS,  and 100 pg/ml sheared and heat- 
denatured salmon sperm DNA.  Hybridization was  carried out at 42"C 
for 16 h in the above solution containing a 32P-oligolabeled (Feinberg and 
Vogelstein, 1983, 1984) fibronectin receptor r  subunit eDNA consisting of 
a 675-bp Barn HI fragment from ZP7 (Argraves et al.,  1986), or nP-oligo- 
labeled vitronectin receptor tt subunit eDNA consisting of a 1,283-bp frag- 
ment from ~.VNR10 (Suzuki et al.,  1986). 
After hybridization the filters were washed in 2x SSC,  1.5 mM sodium 
citrate,  0.1% SDS at room temperature for 1 h followed by lx SSC, 0.1% 
SDS at 65~  for I h. The filters were allowed to air dry and autoradiography 
was carded out at  -70~  using Kodak  XAR-5  film and an intensifying 
screen. 
Results 
Selection of  Cells Resistant to Detachment by the 
GRGDSP Peptide 
When the hexapeptide GRGDSP was added to monolayer 
cultures of MG-63 cells at a concentration of 0.85 raM, the 
cells became detached from the substrate as described previ- 
ously (Hayman et al., 1985). The unattached cells (>99%) 
were removed and fresh medium containing the peptide (0.85 
mM) was added to the remaining cells, some of which also 
detached from the substrate. These remaining few cells were 
incubated in the presence of the peptide and eventually a few 
cells were found to attach and spread. The cells were sup- 
plemented with fresh medium containing peptide and were 
found to be able to attach and grow under these conditions. 
Once confluent, the cells were detached with EDTA and sub- 
cultured in the presence of peptide. The concentration of the 
hexapeptide was subsequently increased from 0.85 to 5.0 mM 
in steps of 0.85 mM over a period of 5 mo, each time select- 
ing for attached cells. 
To address the question of the stability of the peptide for 
long periods in culture, spent medium from cells growing in 
the presence of the peptide for several  days was applied to 
MG-63 cells not previously exposed to the peptide. These 
cells immediately detached from their culture substrates, in- 
dicating that the peptide was still active after several days in 
culture. Replicate cultures were allowed to grow in the pres- 
ence of similar concentrations of a variant hexapeptide previ- 
ously found to be inactive as a cell attachment-promoting 
agent (Pierschbacher and Ruoslahti, 1984a)  and ineffective 
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al., 1985). This peptide, GRGESP, where E is glutamic acid, 
did not have any effect on the MG-63 cells, which grew nor- 
mally and were indistinguishable from MG-63 cells grown 
in the absence of this peptide. 
Physical Characteristics of the Peptide-resistant 
Variant Cells 
The cells capable of attaching and spreading in the presence 
of 5.0 mM of GRGDSP peptide are hereafter called peptide- 
resistant variant (PRV) 1 cells. These cells have a markedly 
different, star-shaped morphology, with multiple processes, 
some of which are many times longer than the cell bodies 
(Fig.  1). These morphologic properties are not unlike those 
of osteocytes (Tritfitt, 1980). The MG-63 cells, on the other 
hand, are essentially flat polygonal cells resembling fibro- 
blasts.  The  PRV  cells  appear  to  interweave and  the  cell 
processes are often seen to make connections with one an- 
other. In addition, the PRV cells appear to be more secretory 
as  judged  by  the  granular  nature  of the  cytoplasm  and 
processes of these cells. PRV cells grown in the absence of 
GRGDSP peptide have maintained this morphology for at 
least 3 too, indicating that this morphologic alteration is a 
stable one. 
1. Abbreviations  used in this  paper: HLA, human leukocyte  antigen; PRV, 
peptide-resistant variant. 
Karyotypic analyses of the two cell lines were carried out 
to ensure that they are related and also to determine whether 
any gross chromosomal changes had taken place in the PRV 
cells as compared with the MG-63 cells. Chromosomes from 
5 MG-63 and 16 PRV cells were analyzed. These analyses 
showed that all of the cells examined from the two cell lines 
had in common nine distinguishable chromosome markers 
(Fig. 2) as well as trisomies of several of the chromosomes 
and the absence of a  normal chromosome 9  (not shown). 
These observations indicate that the PRV cells are indeed 
derived from the MG-63  cells.  No obvious chromosomal 
changes indicative of gene amplification were observed in 
the PRV cells. 
The PRV cells also have different growth properties than 
do the MG-63 cells. They proliferate at a much slower rate, 
requiring at least 15 d to reach confluency as compared with 
the 4 d required for the MG-63 cells when plated at the same 
initial  density.  Moreover,  [3H]thymidine  uptake  studies 
showed that, whereas the MG-63 cells incorporated 82,397 
__+  13,000 cpm/105 cells per 24 h,  the PRV  cells incorpo- 
rated only 8,330 _  420 cpm/l@ cells per 24 h.  These data 
represent means of two separate experiments, each experi- 
ment representing mean values of three measurements. 
Quantitation of  Fibronectin and Vitronectin Receptors 
and Their mRNA in MG-63 and PRV Cells 
Because we expected that a qualitative or quantitative altera- 
tion in some of the RGD-dependent cell adhesion receptors 
Figure 1.  Morphology of MG-63 and PRV cells. Cell monolayers were visualized using a Nikon Diaphot inverted microscope equipped 
with phase-contrast optics. (.4) MG-63 cells, sparse culture; (B) PRV cells, sparse culture; (C) MG-63 cells, dense culture; (D) PRV cells, 
dense culture. Bar, 55 p.m. 
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ison of MG-63 and PRV cells. 
Marker chromosomes common 
to both cell  lines  are shown. 
The  modal  number of chro- 
mosomes was 63 for MG-63 
cells  and  57  for  PRV  cells. 
Chromosomes from 5 MG-63 
and  16  PRV  cells  were ana- 
lyzed.  Pure  trisomies  were 
present in chromosomes 1, 2, 
10,  U, 20, and 22 in the MG- 
63 cells.  Trisomie 11 was not 
present in any of  the PRV cells 
studied  while the other triso- 
mies were maintained  in all of 
the cells.  Chromosome 9 was 
lacking  in all cells  examined. 
would account for their ability to attach to substrate  in the 
presence of high concentrations of the RGD-containing pep- 
tide, we carried out an analysis of the fibronectin and vitro- 
nectin receptors  on these ceils using affinity-purified poly- 
clonal  antibodies  reacting  with  these  two receptors.  Flow 
cytometric analysis of the two cell lines  indicated  that the 
PRV cells had a significant increase in the mean intensity of 
fluorescence as  compared with the MG-63  cells  when the 
fibronectin receptor was probed in indirect immunofluores- 
cence, whereas no difference in the amount of staining of the 
vitronectin  receptors  was  observed  as  compared  with  the 
MG-63  cells  (Fig.  3).  We do not have  adequate  antibody 
probes for the collagen receptor (Dedhar et al.,  1987) at this 
time to have allowed us to examine it in this study, but a simi- 
lar analysis carried out using anti-human leukocyte antigen 
(HLA) and anti-epidermal growth factor receptor antibodies 
showed,  for comparison,  no  significant  differences  in the 
amounts of these antigens present on the surfaces of these 
two cell lines (Fig. 3). Moreover, determinations of cell sizes 
by forward and right-angle light scatter demonstrated that the 
cells had similar sizes in suspension,  indicating that the in- 
creased staining with antifibronectin receptor antibodies in- 
deed reflected the presence of increased amounts of receptor 
on the PRV cells. 
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Figure 3. Expression of  cell surface proteins 
on MG-63 and PRV cells.  Cells  were har- 
vested with 1 mM EDTA and resuspended 
at  a  concentration of 2.5  x  llY-1  x  106 
cells/ml  in  PBS  containing  5%  FCS  and 
0.1% sodium azide. After washing the cells 
with the above buffer 2 vol (with respect to 
the cell pellet) of the respective antibody or 
antiserum was added. After incubation  for 
1 h  at 4~  the cells  were washed  several 
times  in the above buffer and FITC-conju- 
gated goat anti-rabbit IgG was added to the 
cell suspension  and incubated for 30 min at 
4~  After extensive washing, the ceils were 
analyzed using a fluorescence-activated  cell 
sorter (Ortho Cytofluorograf  50H). In each 
case, the broken lines represent  the fluores- 
cence profile of MG-63 cells and the solid 
lines the fluorescence  profile of PRV cells. 
FNR, fibronectin receptor; VNR, vitronec- 
tin receptor; EGFR, epidermal  growth fac- 
tor receptor. 
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of MG-63 and PRV cell sur- 
face  antigens recognized  by 
antibodies.  MG-63 and PRV 
cells  (,'~107) were surface-la- 
beled with  1 mCi ~25I, lysed, 
and the antigens immunopre- 
cipitated as described in Mate- 
rials and Methods. Immuno- 
precipitates were analyzed by 
SDS-PAGE under  nonreduc- 
ing (A) or reducing (B and C) 
conditions.  (A and B) Lanes 
1-3, immunoprecipitation  with 
antifibronectin receptor  anti- 
body; lanes 4-6, immunopre- 
cipitation with antivitronectin 
receptor antibody; lanes 1 and 
4, MG-63 cells (subconfluent 
culture); lanes 2 and 5, PRV 
cells (confluent culture); lanes 
3 and 6, PRV cells (subconflu- 
ent culture). (C) Immunopre- 
cipitation of subconfluent cul- 
tures of MG-63 (lane 1) and 
PRV (lane 2) cells with anti- 
HLA antibody. 
The increase in the number of fibronectin receptors on the 
PRV cells could also be demonstrated by quantitative immu- 
noprecipitation from t25I surface-labeled cells followed by 
SDS-PAGE and autoradiography as shown in Fig. 4. The mo- 
lecular weights of the proteins immunoprecipitated by the 
respective antibodies agree well with the molecular weights 
of  purified receptors for fibronectin (lanes I-3) and vitronec- 
fin (lanes 4-6) and display the characteristic migration pat- 
terns on SDS polyacrylamide gels when subjected to elec- 
trophoresis under nonreducing and reducing conditions (Py- 
tela et al., 1986).  The increase in the number of fibronectin 
receptors on PRV  cells was  quantitated  by densitometric 
scanning of the autoradiographs,  and the amount of each 
subunit was found to be approximately sixfold higher than 
on the parent line of MG-63 cells. A similar analysis of PRV 
cells growing in the absence of GRGDSP peptide demon- 
strated that these cells maintained this increase in fibronectin 
receptor numbers.  The number of vitronectin receptors in 
the PRV cells appears to be similar to that of  the MG-63 cells 
(Fig. 4), consistent with the flow cytometric analysis. Again, 
for comparison, immunoprecipitation of class  1 HLA anti- 
gen with anti-HLA antibodies did not show a  significant 
difference in the amounts of this molecule between the two 
cell lines (Fig. 4 C). These data were consistent in five sepa- 
rate experiments. Furthermore, RNA dot blot analysis of to- 
tal  RNA  from  PRV  and  MG-63  cells  using  32p-labeled 
cDNA for the fibronectin receptor ~t subunit (described in 
Materials and Methods) indicated that the overproduction of 
the fibronectin receptor in the PRV cells correlated with a 
higher level of  fibronectin receptor mRNA as compared with 
the MG-63 cells (Fig.  5).  SDS-PAGE of [3H]leucine- and 
125I surface-labeled MG-63 and PRV cells failed to reveal 
any other major differences in the protein profiles of the two 
cell lines.  Taken together, the above data suggest that the 
PRY cells express more fibronectin receptors than the parch- 
tal MG-63 cells, and this difference appears to be due to a 
difference in the amount of mRNA for the fibronectin recep- 
tor in the two cell lines. 
Southern Blot Analysis 
To see whether gene amplification was the cause of  the fibro- 
nectin receptor overproduction, high molecular weight DNA 
from MG-63 and PRV cells was digested with restriction en- 
donucleases and analyzed by Southern blot analysis. As can 
be seen from Fig. 6, the hybridization signal for representa- 
tive restriction enzyme digests of DNA isolated from both 
Figure 5. Fibroneetin receptor (a subuni0 mRNA levels in MG-63 
and PRV cells. Cytoplasmic RNA was extracted as described in 
Materials and Methods, dotted onto nitrocellulose  filters, and probed 
with 32pdabeled eDNA coding for the r  subunit of the fibroneetin 
receptor. 10-1.25 ~tg RNA were applied in duplicate. (A) PRV cell 
RNA; (B) MG-63 cell RNA. 
Dedhar et al. Bone Differentiation and Cell  Adhesion  1179 Figure 6.  Hybridization of fibronectin and vitronectin  receptor 
cDNA sequences to genomic DNA from MG-63 and PRV cell 
lines. Restriction enzyme digests of high molecular weight human 
DNA (20 p.g) were separated by electrophoresis on an 0.8 % agarose 
gel,  transferred to nitrocellulose filters, and probed with 32P-la- 
beled fibronectin receptor r  subunit cDNA (A and B) or vitronectin 
receptor ct-subunit cDNA (C).  (A) Human placental DNA;  di- 
gested with Eco RI. (B) Lane 1, MG-63 DNA; lane 2, PRV DNA 
digested with Eco RI. (C) Lane 1, MG-63 DNA; lane 2, PRV DNA 
digested with Stu I. 
cell lines is of equivalent intensity when probed with cDNAs 
coding for the ct subunits of the fibronectin receptor or the 
vitronectin receptor. The same results were obtained in sepa- 
rate experiments using other restriction enzymes (not shown). 
It,  therefore, appears that the increased expression of the 
fibronectin receptor in the PRV cells is not due to gene am- 
plification, but is probably due either to an increased rate of 
transcription of the fibronectin receptor gene or to increased 
stability of the receptor mRNA. 
Ability of  MG-63 and PRV Cells to Attach 
to Fibronectin and Vitronectin in the Presence 
of GRGDSP Peptide 
Unless some qualitative change in the receptors had taken 
place,  one  would  predict from the  increased  numbers  of 
fibronectin receptors present on the PRV cells that more pep- 
tide would be required to inhibit attachment of these cells to 
fibronectin than would be required to inhibit attachment of 
the MG-63 ceils to this substrate, whereas similar concentra- 
tions of peptide would be required to inhibit attachment of 
either cell line to vitronectin. This was indeed the case, as 
is shown in Table I. Approximately 25-fold more peptide was 
required to achieve 50% inhibition of maximal attachment 
of PRV  cells to fibronectin as compared with the MG-63 
cells. However, virtually identical concentrations of peptide 
were effective at inhibiting attachment of either cell line to 
vitronectin. These data indicated that the peptide selection 
process  has  resulted  in  cells that  adhere more tightly  to 
fibronectin than do the parental cell line and they suggest 
that, in the presence of the peptide in culture, the PRV ceils 
mainly use the fibronectin receptor, since the amount of pep- 
tide present in the selection medium clearly inhibits attach- 
ment to vitronectin but is not able to inhibit attachment to 
fibronectin (Table I). 
Discussion 
The observation that a synthetic peptide containing the RGD 
cell attachment-promoting sequence derived from the cell- 
binding domain of fibronectin (Pierschbacher and Ruoslahti, 
1984) can detach cells from culture substrates (Hayman et 
al.,  1985) led us to ask the question whether cells selected 
for attachment and growth in the presence of this peptide 
would exhibit alterations  in  the cell surface receptors for 
fibronectin or other RGD-containing  matrix proteins.  We 
show here that the stepwise selection of MG-63 human os- 
teosarcoma cells for attachment and growth in the presence 
of cell attachment-inhibiting concentrations of the synthetic 
peptide, GRGDSP, results in the selection of a cell line capa- 
ble of growing in the presence of this peptide. These PRV 
cells overproduce cell surface receptors for fibronectin as 
compared with the MG-63 cells, and this overproduction is 
due to an increase in the mRNA levels of the receptor. This 
increase is,  however,  not  due  to  the  amplification of the 
fibronectin receptor gene. The PRV cells did not show any 
differences in the amount of vitronectin receptor, epidermal 
growth factor receptor, or HLA expressed on their surface. 
In addition, SDS-PAGE characterization of ~25I-labeled total 
cell surface proteins did not reveal any differences in major 
cell surface proteins between the two cell lines. 
The  PRV  cells have retained the overproduction of the 
fibronectin receptor, the resistance of  detachment from fibro- 
nectin-coated surfaces by the GRGDSP peptide, and the al- 
tered morphology for approximately 6  mo, during the last 
Table L Inhibition of Cell Attachment of  MG-63 and 
PRV Cells to Fibronectin- and Vitronectin-coated  Surfaces 
by GRGDSP Peptide 
Concentration of peptide required 
for 50%  inhibition of maximal cell 
attachment 
Substrate  MG-63  PRV 
mM  mM 
Fibronectin  0.21  5.30 
Vitronectin  0.06  0.07 
Assays were carried out in 96-well microtiter plates as described previously 
(Ruoslahti et al.,  1982). 2 I.tg  of fibronectin and 3 I.tg of vitronectin were coated 
per well and 10,000 cells were used per well. Maximum cell attachment in the 
absence of peptide: 60%  for fibronectin and 80%  for vitronectin. 
The Journal of Cell Biology, Volume  105,  1987  1180 three of which they were grown in the absence of the GRGDSP 
peptide.  This would indicate that the observed changes are 
of a genetic rather than an epigenetic origin. However, no 
gene amplification was observed, and homogeneously stain- 
ing regions or double minute chromosomes (Stark and Wahl, 
1984)  were not detected by the chromosome-banding tech- 
niques used to examine the chromosomes of the two cell 
lines. Therefore, it appears that a mechanism exists by which 
cells can change the amount of fibronectin receptor on their 
surface and consequently alter their adhesive properties. It 
is also interesting that both subunits of the fibronectin recep- 
tor are overproduced, indicating that the subunits  are coor- 
dinately expressed and supporting the idea that both subunits 
are important  for interaction with fibronectin (Buck et al., 
1986;  Santoro and Lawing,  1987). 
It is unlikely that we have selected for a very small sub- 
population of cells present in the original culture that were 
resistant  to the GRGDSP peptide because culturing  MG-63 
cells in the presence of 5 mM GRGDSP peptide (the highest 
concentration  used for selection)  for extended periods re- 
suited in total cell death.  It is more probable that the peptide 
either induced the up-regulation of the fibronectin receptor 
or constituted a sustained selective pressure on cells having 
temporarily increased levels of receptor expression. 
One striking consequence of the peptide selection process 
is the very different morphology of the PRV cells, the most 
obvious manifestation of which are the long interconnecting 
processes present on a majority of the PRV cells. This mor- 
phology is not unlike that of osteocytes, and it is conceivable 
that  the  PRV cells have  undergone modulation to a  more 
differentiated phenotype along the osteocyte lineage. Indeed, 
we have evidence that indicates that the PRV cells are capa- 
ble of forming a calcified matrix, whereas the MG-63 cells 
are not (Dedhar,  S., and M.  Pierschbacher,  manuscript in 
preparation),  though  a direct cause and effect mechanism 
cannot be established by this type of study. However, it is en- 
tirely  possible  that  the  alteration  in cell  shape  may  have 
resulted  in  the  altered  phenotypic  properties  observed  in 
these cells (Watt,  1986;  Bissell et al.,  1982). 
In conclusion, we have shown that it is possible to after the 
expression of fibronectin receptor at the surface of at least 
one cell type in culture by applying an environmental pres- 
sure in the form of a synthetic peptide that inhibits  cell at- 
tachment to fibronectin and vitronectin.  The resulting cell 
line (PRV), which stably overproduces the fibronectin recep- 
tor due to an increased level of expression of the fibronectin 
receptor gene,  is more resistant  to detachment from fibro- 
nectin-coated surfaces than is the MG-63  cell line,  grows 
at  a  much  slower rate,  and  exhibits  a  drastically  altered 
morphology compared with the parental MG-63 cells. A fur- 
ther characterization  and comparison of these two cell lines 
should aid in our understanding  of the role of extracellular 
matrix in cell behavior and gene expression, and also in bone 
cell differentiation. 
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